Bio Integration Achieves new Milestone

We are delighted to announce that with the official release of the 2022 citation metrics in Scopus, the most comprehensive bibliographic database of scientific literature, Bio Integration (BIOI) has a new CiteScore of 4.6 and SNIP 0.868, ranking 22/79 in Category “Biochemistry, Genetics and Molecular Biology (miscellaneous)”

About BIO Integration

BIO Integration (BIOI) seeks to publish multidisciplinary views driving the progress of modern medicine. BIO Integration focuses on original, cutting-edge, interdisciplinary contents in the field of biosciences, including medicine, biochemistry, biophysics, bioengineering and biotechnology, which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine. New methods, important applications, and new interpretations and treatments of existing data, as well as conventional studies in medicine that can be applied to future theranostic applications are encouraged. The journal welcomes the following article types:

• Original Articles
• Reviews
• Mini Reviews (Research Highlights)
• Letters to The Editor
• Editorials
• Editorial Commentaries
• Perspectives/ Opinions
• Case Reports
• Technical Notes
• Brief Reports

Benefits of choosing BIOI for your research

• BIOI is a platinum open access journal which means that your paper is available to anyone in the world to download for free directly from the IngentaConnect website.
• Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
• No Author submission or article processing charges.
• Fast publication online after article acceptance.
• Fast peer review.
• Authors retain the copyright to their article.
• Professional/global marketing/promotion of your articles. Articles are:

• Sent to clinicians and researchers through email alerts;
• Promoted to the Journal followers on Twitter and Facebook;
• Distributed to news outlets through press releases.

For more information on BIOI please see www.bio-integration.org

Submissions to BIO Integration can be made using ScholarOne, the online submission and peer review system. Registration and access are available at  https://mc04.manuscriptcentral.com/bioi There are no author submission or article processing fees.

If you have any queries, please do not hesitate to contact us via email: editorialoffice@bio-integration.org

BIOI articles are available at IngentaConnect.

Articles of interest include:

A Survey on Artificial Intelligence in Chest Imaging of COVID-19

Breast Cancer Multidisciplinary Management during COVID-19 Pandemic: Experiences and Strategies Used by a Singapore Breast Surgical Unit

Artificial Intelligence (AI)-aided Disease Prediction

Nanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy

Enhancing Chemotherapy by RNA Interference

Immunoscore Guided Cold Tumors to Acquire “Temperature” Through Integrating Physicochemical and Biological Methods

Coronavirus Pneumonia and Pulmonary Thromboembolism

Automated Stage Discrimination of Parkinson’s Disease

Drug-induced Interstitial Lung Disease in Breast Cancer Patients: A Lesson We Should Learn From Multi-Disciplinary Integration

New Roles for Clinicians in the Age of Artificial Intelligence

BIO Integration is indexed in Scopus, CAS, DOAJ, Research4Life, Ulrich’s web, OCLC, WorldCat, Primo Central (Ex Libris), Sherpa Romeo and Summon Databases.

Follow BIOI

Twitter @JournalBio

Facebook https://www.facebook.com/BIO-Integration-Journal-108140854107716/